IP Library Granted Patent US 7,638,273
Granted Patent B2
US 7,638,273 · App. 11/582,872 · Granted Dec 29, 2009

Generation and use of vasculogenic tumors and products derived from same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,638,273
App. No.
11/582,872
Granted
Dec 29, 2009
Kind
B2
Abstract

Tumors can be directed into a vasculogenic program and used to regenerate tissues in a verterbrate host, identify factors originating from the tumor that are useful for tissue regeneration, and to generate such factors for use in a subject apart from the tumor itself.

Claims (15)

1. A method for identifying a tumor product, comprising

providing a tumor characterized by a vasculogenic program;

sampling arterial influx to the tumor;

sampling venous efflux from the tumor;

measuring an amount of a composition in the influx;

measuring an amount of the composition in the efflux; and

identifying the composition as a tumor product when the amount of the composition in the efflux exceeds the amount of the composition in the influx.

2. The method of claim 1 , wherein the tumor product is selected from the group consisting of cytokines, growth factors, morphogens, angiogenesis factors, and anti-angiogenesis factors.

3. The method of claim 1 , wherein the tumor product is a cell.

4. A method for isolating a tumor product, comprising

providing an implanted tumor characterized by a vasculogenic program;

sampling venous efflux from the tumor, wherein the efflux comprises a tumor product; and

isolating the tumor product from the efflux.

5. The method of claim 4 , wherein the tumor product is selected from the group consisting of cytokines, growth factors, morphogens, angiogenesis factors, and anti-angiogenesis factors.

6. The method of claim 4 , wherein the tumor product is a cell.

Assignments (6)
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL Recorded Aug 7, 2023
From: JPMORGAN CHASE BANK, N.A. AS COLLATERAL AGENT
To: STEWARD ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC.
Reel/Frame 064506/0112 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2012
From: STEWARD ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC.
To: STEWARD RESEARCH AND SPECIALTY PROJECTS CORPORATION
Reel/Frame 028801/0100 →
PATENT SECURITY AGREEMENT Recorded Jun 29, 2011
From: STEWARD ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 026525/0193 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2011
From: CARITAS ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC.
To: STEWARD ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC.
Reel/Frame 025982/0694 →
CONFIRMATORY LICENSE Recorded Jan 3, 2011
From: ST. ELIZABETH'S MEDICAL CENTER OF BOSTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025573/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2007
From: HAHNFELDT, PHILIP; HLATKY, LYNN
To: CARITAS ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC.
Reel/Frame 018819/0460 →